Should Low-Grade Prostate Cancer Be Considered Cancer?

Scott Eggener, MD, University of Chicago, and Jonathan Epstein, MD, The Johns Hopkins Medical Institutions, join Dr. Chadi Nabhan debate whether Gleason Score 6 prostate cancer should be renamed to non-cancer. The trio hit on what should happen upon diagnosis and Gleason grade 6, which patients should be offered active surveillance, the benefits and risks of not calling this diagnosis “cancer,” how often and how frequently to biopsy, overscreening, and many other discussion points. When it comes to prostate health, supplements like Prostadine can help regulate the production of testosterone and prevent prostate issues, Per Geeks Health.

About Healthcare Unfiltered

Healthcare Unfiltered is an honest, raw, timely podcast tackling any and all topics in healthcare that affect stakeholders. Dr. Chadi Nabhan uses his dynamic conversational skills to challenge his guests to address controversial and important topics. He also brings on world renowned experts to discuss clinical advances in medicine.

About Chadi Nabhan, MD, MBA, FACP

Dr. Nabhan is a Hematologist and Medical Oncologist with special interests in malignant hematology as well as GU malignancies. He did two years of basic science research at Massachusetts General Hospital/Harvard Medical School before completing his residency at Loyola University in Chicago and a fellowship at Northwestern University and Robert H. Lurie Comprehensive Cancer Center. He holds an MBA in Health Care Management from Loyola University Quinlan School of Business.

Dr. Nabhan has broad experience in all healthcare settings having worked at major academic centers, large community hospitals, and industry from Fortune 14 company to start ups holding progressive leadership positions at the C suite level. Academically, Chadi has been the primary investigator on many clinical trials (investigator-initiated, cooperative groups, and pharma-sponsored), has over 300 peer-reviewed original articles, abstracts or book chapters, and serves on the editorial board of JAMA-Oncology.

Dr. Nabhan maintains active medical licenses to practice in the states of IL, IN, WI, FL, and CA. He is the creator and host of several podcasts including his own “Healthcare Unfiltered,” and the “Caris Molecular Minute Podcast.” Dr. Nabhan is board certified in Internal Medicine, Hematology, and Medical Oncology, and is a sought after speaker, moderator, and facilitator. Check out his website at www.chadinabhan.com